Aim: This study aims to determine the association between glucose metabolism and proinflammatory/anti-inflammatory properties of circulating monocytes or those of carotid plaques in patients who underwent carotid endarterectomy. Methods: Clinical characteristics and expression levels of proinflammatory/anti-inflammatory markers in circulating monocytes/carotid plaques were examined in 12 patients with diabetes and 12 patients without diabetes. Results: Circulating monocytes from patients with diabetes revealed higher tumor necrosis factor (TNF)-and lower interleukin (IL)-10 expression levels compared with those from patients without diabetes, which was also observed in carotid plaques from patients with diabetes. Hyperglycemia revealed positive and negative correlations with the ratios of IL-6 and IL-10 cells in carotid plaques, respectively. Moreover, we determined a positive correlation between circulating monocytes and carotid plaques with respect to TNF-and IL-6 expressions. Conclusions: The inflammatory property of circulating monocytes was associated with that of carotid plaques. Hyperglycemia increased inflammatory properties and decreased anti-inflammatory properties of carotid plaques.
Introduction
Type 2 diabetes contributes to an increased risk of developing atherosclerotic diseases such as coronary heart disease and stroke 1, 2) . The Hisayama study demonstrated that diabetes is an independent risk factor for ischemic stroke in the Japanese population 3) . Therefore, it is of clinical importance to predict and evaluate the onset of stroke in patients with diabetes. The monocyte/macrophage (M ) system plays critical roles in the pathogenesis of inflammatory diseases, including atherosclerosis. This system demonstrates at least two distinct phenotypes of differentiation: proinflammatory (M1) and anti-inflammatory (M2) 4, 5) . M1 M in atherosclerotic plaques secrete inflammatory cytokines, such as tumor necrosis factor-(TNF-), and promote plaque development and rupture, thereby contributing to the formation of atherothrombosis 6, 7) . Regarding the properties of circulating monocytes, this and other studies previously reported the unfavorable inflammatory balance of M1/M2-like phenotypes of circulating monocytes in obese patients with and without diabetes 4, 8) . This study was designed to elucidate the association of glucose metabolism and inflammatory/anti-inflammatory properties of circulating monocytes with those of carotid plaques in Copyright©2016 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.
Statistical Analysis
If normally distributed, continuous data were reported as mean standard deviation, and if not normally distributed, they were reported as median and interquartile range (IQR). Student's t-test was used for comparisons of the means between the two groups. If data were not normally distributed, the Mann-Whitney U test was used. For comparisons of the median among the ratios of immunohistochemically positive cells, the Wilcoxon signed-rank test was used. Spearman's rank correlation coefficient ( ) was used to investigate the correlations between proinflammatory/ anti-inflammatory parameters (expression levels in circulating monocytes and carotid plaques and percentage of positive cells in the plaque) and metabolic parameters. Moreover, Spearman's partial rank correlation coefficients ( pa) were obtained by employing medications (calcium antagonist, ACE/ARB, and statins) as control variables. A P value of 0.05 was considered significant. All statistical analyses were performed with SPSS v.22.0 for Windows (IBM Japan, Ltd., Tokyo, Japan).
Results
Of all 24 patients who underwent CEA (12 with diabetes and 12 without diabetes; mean age, 72.3 8.2 years), the serum FPG and HbA1c levels were significantly higher in patients with diabetes than in patients without diabetes (P 0.001) ( Table 1) . To elucidate the impact of diabetes on proinflammatory/antiinflammatory properties of circulating monocytes and carotid plaques, we examined TNF-, IL-6, and IL-10 expression levels in these cell types and the ratios of cells expressing the cytokines in the plaques ( Table 2 and Fig. 1 ). As shown in Table 2 , we found that the relative mRNA level of TNF-[median, 1.7 (IQR, 1.0-5.6)] was significantly higher and that of IL-10 [0.4 (0.2-0.9)] was significantly lower in circulating monocytes of patients with diabetes than in those of patients without diabetes [TNF-, 1.0 (0.8-1.7), P 0.049; IL-10, 1.0 (0.3-1.4), P 0.025]. With respect to carotid plaques, we found that both the relative mRNA levels of TNF-[1.7 (1.1-3.3)] and IL-6 [1.8 (1.0-4.1)] were significantly higher in the carotid plaques of patients with diabetes than in those of patients without diabetes [TNF-, 1.0 (0.7-2.0), P 0.042; IL-6, 1.0 (0.5-1.1), P 0.038]. In addition, the percentage of IL-6 cells [63.2 (40.8-71.1)] was significantly higher and that of IL-10 cells [58.0 (37.6 -65.2)] was significantly lower in carotid plaques of patients with diabetes than in those of patients with diabetes [IL-6 , 42.9 (38.7-54.9), P 0.040; IL-10 , 70.9 (59.3-83.7), P 0.019].
patients who underwent carotid endarterectomy (CEA).
Methods

Subjects
A total of 24 male Japanese patients with advanced carotid plaques who underwent CEA were recruited from the Department of Neurosurgery of our hospital. The study protocol was approved by the Ethics Committee for Human Research at the Kyoto Medical Center (ID: 11-06). Written informed consent was obtained from all participants. This study is registered in the University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR) System (ID: UMIN000019115).
Data Collection and Laboratory Methods
Anthropometric and metabolic parameters were measured as previously described 5, 9, 10) . The HbA1c levels were measured before the meal on the day prior to CEA. The insulin resistance index was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR). Human circulating monocytes were obtained from blood samples and were analyzed as previously described 5, 9, 10) . In brief, peripheral blood mononuclear cells were collected from heparinized blood samples by density-gradient centrifugation with lymphocyte separation solution (Nacalai Tesque, Kyoto, Japan) before the meal on the day prior to CEA. Circulating monocytes were then isolated by magnetic-activated cell sorting with anti-human CD14 immunomagnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany).
The expression levels of genes of interest were analyzed using quantitative RT-PCR and immunohistochemistry using standard procedures 5, 9-11) . The primers used in the assays were purchased from SigmaAldrich (Tokyo, Japan), and the primer sequences are listed in Supplementary Table 1 2). Furthermore, our data revealed that the MHCratio was significantly higher than the CD3 ratio in carotid plaques of both patient without diabetes [75.4 (66.4-78.8) and 10.3 (8.6-14.0), P 0.002] and those with diabetes [83.1 (73.7-88.1) and 13.0 (8.9-15.0), P 0.002], thereby suggesting that the M ratio was higher than the T-cell ratio in carotid plaques of both patients.
Next, we examined the correlation between glucose metabolism and inflammatory properties of carotid plaques in all patients who underwent CEA. As shown in Table 3 and Fig. 2 , we found that FPG and HbA1c levels displayed significant negative correlations with the IL-10 ratio in carotid plaques [FPG, 0.471, P 0.020 (Fig. 2a) ; HbA1c, 0.428, P 0.037 ( Fig. 2b) ]. Furthermore, IRI and HOMA-IR revealed significant negative correlations with the IL-10 ratio in carotid plaques (IRI, 0.543, P 0.006; HOMA-IR, 0.640, P 0.001) ( Table  3) . Moreover, as shown in Tables 3 and 4 and Fig. 3 , To further examine the properties of circulating monocytes and carotid plaques, we analyzed the expression levels of cell-surface markers for proinflammatory/anti-inflammatory properties of circulating monocytes/M . Circulating monocytes are classified by the expression levels of markers, such as CD14, CD16, and CD68, thereby reflecting different inflammatory states 12, 13) . Furthermore, MHC-, a marker of circulating monocytes/M , and CD86 are upregulated in M1 M , whereas CD206 and Dectin-1 are highly expressed in M2 M [14] [15] [16] . As shown in Table 2 and Fig. 1b , we found no significant difference between patients with and without diabetes with respect to the expression levels of these markers in circulating monocytes and carotid plaques. This differed from that observed for proinflammatory/anti-inflammatory cytokine levels ( Table 2 and Fig. 1a) . Furthermore, we found that the ratio of cells expressing CD3, a T-cell marker, in plaques was not significantly different between patients with and without diabetes ( Table   Table 1 to the case of single correlation analyses in Table 3 and Fig. 2 . Furthermore, we found a significant positive correlation between HbA1c levels and the IL-6 ratio in carotid plaques ( pa 0.606, P 0.006).
We further addressed the association between circulating monocytes and carotid plaques with regard to the proinflammatory/anti-inflammatory cytokine levels in all patients who underwent CEA (Tables 3 and 4). We observed that the TNF-expression level in circulating monocytes was positively correlated with the TNF-ratio ( 0.444, P 0.034) ( Table 3) and TNF-expression level ( 0.459, P 0.027) (Table 4) in carotid plaques. In addition, the IL-6 expression level in circulating monocytes revealed a significant positive correlation with that in carotid plaques ( HbA1c levels revealed significant positive correlations with the IL-6 ratio ( 0.466, P 0.022) ( Table 3 and Fig. 3a) and TNF-expression levels ( 0.527, P 0.01) ( Table 4 and Fig. 3b ) in carotid plaques. The HbA1c level was not significantly correlated with the expression levels of cell-surface markers, such as MHC-, CD86, CD206, and Dectin-1, and the ratios of MHC-, CD86 , CD206 , and CD3 cells in carotid plaques. In partial rank correlation analyses employing medications as control variables, we observed significant negative correlations between glucose metabolism and the IL-10 ratio in carotid plaques (FPG, pa 0.488, P 0.034; IRI, pa 0.540, P 0.017; HbA1c, pa 0.452, P 0.048; and HOMA-IR, pa 0.629, P 0.004), which is similar Table 4) but not with the IL-6 ratio in carotid plaques (Table 3) . Conversely, no significant correlation was observed with respect to the by M in atherothrombotic plaques is impaired in patients with acute coronary syndrome having diabetes and insulin resistance 18) . Therefore, hyperglycemia may be involved in the reduced anti-inflammatory properties of M in carotid plaques.
A recent epidemiological study, the Malmo Diet and Cancer study, reported that elevated CD14 high CD16 monocytes in a heterogeneous monocyte population can predict cardiovascular events 19) . On the other hand, Fadini et al. 13) reported that the functions of inflammatory and anti-inflammatory monocytes rather than traditional cell-surface markers are associated with microangiopathy in patients with diabetes 13) . In addition, Neele et al. 20) reported that surface markers expressed by M do not reveal the activation status of M 20) . Similarly, in this study, no significant difference was observed between patients with and without diabetes with regard to the expression levels of cell-surface markers for inflammatory/anti-inflammatory properties in circulating monocytes and carotid plaques. However, data regarding the proinflammatory/anti-inflammatory cytokine expression levels revealed that inflammatory properties of circulating monocytes and carotid plaques were more exacerbated in patients with diabetes than in those without diabetes. Furthermore, we found that these inflammatory properties were aggravated in patients with advanced diabetes. Accordingly, our data reported for the first time that inflammatory properties of circulating monocytes/M were exacerbated in the absence of remarkable changes of cell-surface inflammatory/antiinflammatory markers in patients with diabetes. Further studies are required to clarify the mechanisms by which the cytokine expression is influenced by diabetes in the absence of concomitant changes of cell-surface markers.
Carotid ultrasonography may be a useful tool for predicting the atherosclerotic status of coronary arteries 21) ; however, the association between circulating monocytes and carotid plaques pertaining inflammatory/anti-inflammatory properties remains unclear. On the basis of the proinflammatory/anti-inflammatory cytokine expression levels, we demonstrated for the first time that inflammatory properties of circulating monocytes are positively correlated with those of carotid plaques. In a previous study involving histological and gene expression analyses of carotid plaques, a higher gene expression level of inflammatory cytokines in carotid plaques was correlated with the morphological features of a more advanced or an unstable condition 22) . Moreover, the balance between proinflammatory/pro-thrombotic and anti-inflammatory mediators in mononuclear cells of carotid plaques may modulate plaque progression 23) . Therefore, our findplaques regarding inflammatory properties were also obtained by partial rank correlation analyses, wherein medications were control variables.
Finally, we investigated the association between clinical settings and proinflammatory/anti-inflammatory properties of circulating monocytes and carotid plaques. We found that the properties of circulating monocytes and carotid plaques did not significantly correlate with the duration of diabetes (Supplementary Table 2 ). One of the 12 patients with diabetes had a transient weakness, but all the patients had no paralysis and were able to walk. Regarding the severity of diabetes, we found that the TNF-expression level was significantly higher in circulating monocytes of patients with diabetes having neuropathy [8 patients, 4.0 (1.8-8.2)] than in those of patients with diabetes not having neuropathy [4 patients, 1.0 (0.9-1.2), P 0.014]. In addition, the IL-10 expression level was significantly lower in carotid plaques of patients with diabetes having a stroke [6 patients, 0.4 (0.2-0.8)] than in those of patients with diabetes not having a stroke [6 patients, 1.0 (0.7-1.2), P 0.036]. Consequently, we suggest that inflammatory properties of circulating monocytes and carotid plaques are exacerbated in patients with advanced diabetes.
Discussion
This study is the first to demonstrate that carotid plaques from patients with diabetes have a higher ratio of inflammatory cells and a lower ratio of anti-inflammatory cells compared with those from patients without diabetes. Furthermore, anti-inflammatory properties of carotid plaques were decreased by hyperglycemia. Moreover, we observed a positive correlation between circulating monocytes and carotid plaques, particularly with regard to inflammatory properties. These findings suggest that hyperglycemia and inflammatory properties of circulating monocytes are closely associated with inflammatory properties of carotid plaques in patients who underwent CEA.
Hyperglycemia causes endothelial cell damage, triggering monocyte recruitment 17) . In addition, circulating monocytes with inflammatory properties display an intrinsically higher transendothelial migratory capacity than those with anti-inflammatory properties 13) . Therefore, our findings suggest that circulating monocytes with inflammatory properties infiltrate carotid plaques and differentiate into M1 M more efficiently relative to circulating monocytes with antiinflammatory properties in patients with hyperglycemia. Alternatively, hyperglycemia may have deleterious impact on IL-10 production in M in carotid plaques. Sato T et al. reported that IL-10 production
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This work was supported in part by a Grant-inings suggest that inflammatory properties of circulating monocytes are useful as potential novel markers for evaluating atherosclerosis progression and predicting cardiovascular risk, thereby leading to novel therapeutic targets.
This study had some limitations. This study included a cohort comprising 24 males. A study with a larger sample size would further clarify the association between glucose metabolism and proinflammatory/anti-inflammatory properties of circulating monocytes and carotid plaques. Furthermore, a cohort study comprising females would be informative. In this study, the expression of the genes of interest in carotid plaques was analyzed using plaque tissues. Because carotid plaques contain multiple cell types, the difference in mRNA levels, such as IL-10 levels, in carotid plaques between patients with and without diabetes may be vague. Furthermore, Saraiva et al. 24) reported several mechanisms of posttranscriptional regulation with an impact on IL-10 mRNA half-life and on the amount of IL-10 secretion in M 24) . Hence, the inconsistency between immunohistochemical and plaque mRNA data may be attributable to these mechanisms. In addition, a longitudinal study would help to provide novel insights in the correlation between proinflammatory/anti-inflammatory properties of circulating monocytes and/or carotid plaques and prognosis of patients who underwent CEA.
Finally, further investigation in larger cohorts with more extensive phenotypic analyses of circulating monocytes would be expected to elucidate the critical types of circulating monocytes, thereby providing further insights into the diagnostic significance of circulating monocytes in evaluating atherosclerosis and cardiovascular disease progression.
Conclusion
Hyperglycemia and inflammatory properties of peripheral blood monocytes demonstrated positive correlations with inflammatory properties of carotid plaques in patients who underwent CEA. Inflammatory properties of circulating monocytes may be potential novel markers for evaluating atherosclerosis progression. 
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